List of Contents

Cancer Registry Software Market Size, Share, and Trends 2024 to 2034

The global cancer registry software market size was accounted for USD 84.16 million in 2024, grew to USD 94.68 million in 2025 and is predicted to surpass around USD 273.29 million by 2034, representing a healthy CAGR of 12.50% between 2025 and 2034. The North America cancer registry software market size was calculated at USD 36.92 million in 2024 and is expected to grow at a fastest CAGR of 12.51% during the forecast year.

  • Last Updated : December 2024
  • Report Code : 1625
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cancer Registry Software Market 

5.1. COVID-19 Landscape: Cancer Registry Software Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cancer Registry Software Market, By Software Type

8.1. Cancer Registry Software Market, by Software Type, 2025-2034

8.1.1. Cross disciplinary

8.1.1.1. Market Revenue and Forecast (2022-2034)

8.1.2. Specific

8.1.2.1. Market Revenue and Forecast (2022-2034)

Chapter 9. Global Cancer Registry Software Market, By Deployment Model Type

9.1. Cancer Registry Software Market, by Deployment Model Type, 2025-2034

9.1.1. On-premise

9.1.1.1. Market Revenue and Forecast (2022-2034)

9.1.2. Cloud-based

9.1.2.1. Market Revenue and Forecast (2022-2034)

Chapter 10. Global Cancer Registry Software Market, By End Use Type 

10.1. Cancer Registry Software Market, by End Use Type, 2025-2034

10.1.1. Government and third party

10.1.1.1. Market Revenue and Forecast (2022-2034)

10.1.2. Private payers

10.1.2.1. Market Revenue and Forecast (2022-2034)

10.1.3. Hospital and medical practice

10.1.3.1. Market Revenue and Forecast (2022-2034)

10.1.4. Pharma biotech and medical device companies

10.1.4.1. Market Revenue and Forecast (2022-2034)

10.1.5. Research institutes

10.1.5.1. Market Revenue and Forecast (2022-2034)

Chapter 11. Global Cancer Registry Software Market, By Functionality Type

11.1. Cancer Registry Software Market, by Functionality Type, 2025-2034

11.1.1. Cancer Reporting to Meet State & Federal Regulations

11.1.1.1. Market Revenue and Forecast (2022-2034)

11.1.2. Patient Care Management

11.1.2.1. Market Revenue and Forecast (2022-2034)

11.1.3. Product Outcome Evaluation

11.1.3.1. Market Revenue and Forecast (2022-2034)

11.1.4. Medical Research and Clinical Studies

11.1.4.1. Market Revenue and Forecast (2022-2034)

Chapter 12. Global Cancer Registry Software Market, By Component Type

12.1. Cancer Registry Software Market, by Component, 2025-2034

12.1.1. Commercial

12.1.1.1. Market Revenue and Forecast (2022-2034)

12.1.2. Public

12.1.2.1. Market Revenue and Forecast (2022-2034)

Chapter 13. Global Cancer Registry Software  Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Software (2022-2034)

13.1.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.1.3. Market Revenue and Forecast, by End Use (2022-2034)

13.1.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.1.5. Market Revenue and Forecast, by Component (2022-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Software (2022-2034)

13.1.6.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.1.6.3. Market Revenue and Forecast, by End Use (2022-2034)

13.1.6.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.1.7. Market Revenue and Forecast, by Component (2022-2034) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Software (2022-2034)

13.1.8.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.1.8.3. Market Revenue and Forecast, by End Use (2022-2034)

13.1.8.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.1.8.5. Market Revenue and Forecast, by Component (2022-2034)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Software (2022-2034)

13.2.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.2.3. Market Revenue and Forecast, by End Use (2022-2034)

13.2.4. Market Revenue and Forecast, by Functionality (2022-2034) 

13.2.5. Market Revenue and Forecast, by Component (2022-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Software (2022-2034)

13.2.6.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.2.6.3. Market Revenue and Forecast, by End Use (2022-2034)

13.2.7. Market Revenue and Forecast, by Functionality (2022-2034) 

13.2.8. Market Revenue and Forecast, by Component (2022-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Software (2022-2034)

13.2.9.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.2.9.3. Market Revenue and Forecast, by End Use (2022-2034)

13.2.10. Market Revenue and Forecast, by Functionality (2022-2034)

13.2.11. Market Revenue and Forecast, by Component (2022-2034)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Software (2022-2034)

13.2.12.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.2.12.3. Market Revenue and Forecast, by End Use (2022-2034)

13.2.12.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.2.13. Market Revenue and Forecast, by Component (2022-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Software (2022-2034)

13.2.14.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.2.14.3. Market Revenue and Forecast, by End Use (2022-2034)

13.2.14.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.2.15. Market Revenue and Forecast, by Component (2022-2034)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Software (2022-2034)

13.3.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.3.3. Market Revenue and Forecast, by End Use (2022-2034)

13.3.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.3.5. Market Revenue and Forecast, by Component (2022-2034)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Software (2022-2034)

13.3.6.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.3.6.3. Market Revenue and Forecast, by End Use (2022-2034)

13.3.6.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.3.7. Market Revenue and Forecast, by Component (2022-2034)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Software (2022-2034)

13.3.8.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.3.8.3. Market Revenue and Forecast, by End Use (2022-2034)

13.3.8.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.3.9. Market Revenue and Forecast, by Component (2022-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Software (2022-2034)

13.3.10.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.3.10.3. Market Revenue and Forecast, by End Use (2022-2034)

13.3.10.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.3.10.5. Market Revenue and Forecast, by Component (2022-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Software (2022-2034)

13.3.11.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.3.11.3. Market Revenue and Forecast, by End Use (2022-2034)

13.3.11.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.3.11.5. Market Revenue and Forecast, by Component (2022-2034)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Software (2022-2034)

13.4.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.4.3. Market Revenue and Forecast, by End Use (2022-2034)

13.4.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.4.5. Market Revenue and Forecast, by Component (2022-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Software (2022-2034)

13.4.6.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.4.6.3. Market Revenue and Forecast, by End Use (2022-2034)

13.4.6.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.4.7. Market Revenue and Forecast, by Component (2022-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Software (2022-2034)

13.4.8.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.4.8.3. Market Revenue and Forecast, by End Use (2022-2034)

13.4.8.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.4.9. Market Revenue and Forecast, by Component (2022-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Software (2022-2034)

13.4.10.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.4.10.3. Market Revenue and Forecast, by End Use (2022-2034)

13.4.10.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.4.10.5. Market Revenue and Forecast, by Component (2022-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Software (2022-2034)

13.4.11.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.4.11.3. Market Revenue and Forecast, by End Use (2022-2034)

13.4.11.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.4.11.5. Market Revenue and Forecast, by Component (2022-2034)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Software (2022-2034)

13.5.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.5.3. Market Revenue and Forecast, by End Use (2022-2034)

13.5.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.5.5. Market Revenue and Forecast, by Component (2022-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Software (2022-2034)

13.5.6.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.5.6.3. Market Revenue and Forecast, by End Use (2022-2034)

13.5.6.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.5.7. Market Revenue and Forecast, by Component (2022-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Software (2022-2034)

13.5.8.2. Market Revenue and Forecast, by Deployment Model (2022-2034)

13.5.8.3. Market Revenue and Forecast, by End Use (2022-2034)

13.5.8.4. Market Revenue and Forecast, by Functionality (2022-2034)

13.5.8.5. Market Revenue and Forecast, by Component (2022-2034)

Chapter 14. Company Profiles

14.1. Rocky Mountain Cancer Data Systems

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. McKesson Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Onco Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Elekta AB

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. IBM Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. C/Net Solutions

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Ordinal Data Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Himagine Solutions Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Electronic Registry Systems Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. CONDUENT Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global cancer registry software market size was reached at USD 84.16 million in 2024 and is anticipated to rake USD 273.29 million by 2034.

The global cancer registry software market is expanding growth at a CAGR of 12.50% from 2025 to 2034.

The major players operating in the cancer registry software market are Rocky Mountain Cancer Data Systems, McKesson Corporation, Onco Inc., Elekta AB, IBM Corporation, C/Net Solutions, Ordinal Data Inc., Himagine Solutions Inc., Electronic Registry Systems Inc., and CONDUENT Inc.

One of the key factors driving the growth of the global cancer registry software market is growing incidence of cancer globally. The growing geriatric population is also driving the growth of the cancer registry software market over the forecast period.

North America region will dominate the cancer registry software market during the forecast period 2025 to 2034.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us